Phillip McGill represents clients on corporate and securities law matters with an emphasis on public company representation. He regularly advises public companies on complex public offerings and private placements, SEC and securities exchange reporting and compliance, corporate governance issues and strategic transactions. Private companies rely on him for his experience in guiding clients through formation and various stages of financing with a view towards preparing for strategic transactions and initial public offerings. Phil counsels clients in diverse industries, including agriculture, biotechnology, financial services, healthcare, information technology, medical device and software.

Download full bio 


  • Origin to List on Nasdaq via SPAC Merger With Artius 

  • Castle Biosciences $74 Million IPO 

  • Atlassian - $531 Million IPO 

  • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 

  • Cidara Completes Initial Public Offering  

  • View all


  • University of San Diego School of Law
    JD, magna cum laude, Order of the Coif, 2013

  • University of California, Irvine
    BA, Political Science, minor in Accounting
    cum laude, 2008

Admissions & Credentials



  • State Bar of California